D-Dopa Tablet 100 mg+10 mg is a combination therapy containing Levodopa and Carbidopa, designed to manage Parkinson’s disease and other movement disorders caused by dopamine deficiency. Parkinson’s disease is a neurodegenerative disorder marked by reduced dopamine levels in the brain, leading to tremors, stiffness, slowness of movement (bradykinesia), and impaired coordination.

Levodopa replenishes dopamine in the central nervous system, helping restore normal communication between neurons and improving motor control. Carbidopa inhibits the peripheral breakdown of Levodopa, ensuring more of the active drug reaches the brain while reducing side effects like nausea and low blood pressure.

D-Dopa Tablet 100 mg+10 mg is formulated for oral administration and is ideal for patients starting therapy or requiring lower doses for precise titration of treatment. It provides a convenient and reliable option to improve daily functioning and quality of life for individuals living with Parkinson’s disease.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Levodopa is a precursor to dopamine, which crosses the blood-brain barrier and is converted into dopamine within the brain. This replenishes deficient neurotransmitter levels and restores dopaminergic signaling, which is essential for controlling voluntary movements.

Carbidopa inhibits the enzyme aromatic L-amino acid decarboxylase (DOPA decarboxylase) in peripheral tissues, preventing the premature conversion of Levodopa to dopamine outside the brain. This increases Levodopa bioavailability in the central nervous system and reduces peripheral side effects such as nausea, vomiting, and hypotension.

Together, Levodopa and Carbidopa improve motor function, reduce tremors, and enhance overall mobility in patients with Parkinson’s disease.

Indications

D-Dopa Tablet 100 mg+10 mg is indicated for:

• Parkinson’s disease – for controlling motor symptoms including tremors, rigidity, and bradykinesia

• Parkinsonism due to other causes such as post-encephalitic or drug-induced parkinsonism

• Early or low-dose therapy for patients requiring gradual titration of Levodopa

• Adjunct therapy in movement disorders requiring dopamine replacement

It is suitable for both newly diagnosed patients and those who need individualized dose adjustment.

Dosage and Administration

The dosage of D-Dopa Tablet 100 mg+10 mg is determined by the patient’s condition, age, and response to therapy.

• Tablets are taken orally, with or without food, following the prescribed schedule.

• Initial therapy usually begins with one tablet 2–3 times daily, which can be gradually adjusted based on response and tolerability.

• Maintaining consistent dosing schedules is essential to minimize fluctuations in symptom control and reduce the risk of motor complications.

• Regular follow-up with a physician is necessary for dose adjustments as Parkinson’s disease progresses.

Precautions and Warnings

• Use cautiously in patients with cardiovascular disease, glaucoma, or psychiatric disorders.

• Abrupt discontinuation may worsen Parkinsonian symptoms or cause sudden immobility.

• May cause drowsiness or dizziness; avoid driving or operating machinery until the individual response is known.

• Inform the physician about any concurrent medications, including MAO inhibitors, antipsychotics, or antihypertensives.

• Periodic monitoring of blood pressure, liver, and kidney function may be recommended.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Nausea, vomiting, or loss of appetite

• Dizziness or orthostatic hypotension

• Dyskinesia (involuntary movements) with long-term use

• Sleep disturbances or vivid dreams

• Rare psychiatric effects, such as hallucinations or confusion

Careful dose titration and timing of administration can help minimize these side effects.

Storage Instructions

Store D-Dopa Tablet 100 mg+10 mg in a cool, dry place, protected from light and moisture. Keep out of reach of children.

D-Dopa Tablet 100 mg+10 mg provides a flexible and effective therapy for Parkinson’s disease, offering symptom control, improved mobility, and enhanced quality of life through the synergistic effects of Levodopa and Carbidopa.